Brief: TCR² Therapeutics Announces Proposed Public Offering Of Common Stock
27/07/2020 21:13
July 27 (Reuters) - TCR2 Therapeutics Inc TCRR.O :
* TCR² THERAPEUTICS ANNOUNCES PROPOSED PUBLIC OFFERING OF
COMMON
STOCK
* SAYS OFFERING 6.00 MILLION COMMON SHARES
* SAYS OFFERING 6.00 MILLION COMMON SHARES
Source text for Eikon: ID:nGNX2SGm9P
Further company coverage: TCRR.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on TCR2 Therapeutics
See all newsBrief: TCR2 Therapeutics Entered Into An Assignment Of Lease Agreement With Astrazeneca
TCR2 Therapeutics falls on bigger-than-expected Q1 loss
Brief: Tcr² Therapeutics Reports Q1 2023 Financial Results And Provides Corporate Update
TCR2 Therapeutics Inc reports results for the quarter ended in March - Earnings Summary
TCR2 Therapeutics Inc expected to post a loss of 68 cents a share - Earnings Preview